Clinical Trials
Study Title:
Randomized Phase II/III Trial of Radiation with High Dose Cisplatin (100mg/m2) Every Three Weeks Versus Radiation with Low Dose Cisplatin (40mg/m2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Bhishamjit Chera, at cherabs@musc.edu. Study Coordinator, Madison Avinger, at avingerm@musc.edu.
Self Regional Medical Center Affiliate Principal Investigator, Clint Wood, at clint.wood@selfregional.org. Study Coordinator, Lydia Moats, at lydia.moats@selfregional.org.
Trial opened at the following institutions: Medical University of South Carolina, Self Regional Medical Center |